Target intelligence / Profile preview

Probable G-protein coupled receptor 141 (GPR141)

Target
GPR141
Molecular classification
G protein-coupled receptor, Receptor, Rhodopsin family (Class A/1 GPCR)
01

Overview

Probable G-protein coupled receptor 141 (GPR141) is an orphan Class A (rhodopsin-like) G protein-coupled receptor encoded by the GPR141 gene in humans[3][4][6]. Highly expressed in myeloid-lineage cells such as neutrophils, monocytes, macrophages, and dendritic cells, GPR141 functions as a negative regulator of immune responses and inflammation, notably by suppressing excessive myeloid cell activation[1]. Recent research indicates GPR141 is a promoter of breast cancer proliferation, migration, and epithelial to mesenchymal transition by modulating p53 and mTOR1 signaling and influencing the tumor microenvironment[2][4]. Although not yet targeted by approved drugs, GPR141 is under investigation as a potential therapeutic target for both cancer and immune-mediated disorders.

Other names
PGR13G-protein coupled receptor PGR13putative G-protein coupled receptor 141probable G-protein coupled receptor 141
02

Mechanism of action

No approved drugs; mechanism of action inferred from gene/protein modulation studies—e.g., GPR141 knockdown impedes breast cancer proliferation through p53 restoration and mTOR1 pathway attenuation.

03

Biological functions

Signal transductionRegulation of immune response (particularly in myeloid-lineage cells, monocytes, macrophages, dendritic cells)Negative regulator of inflammationRegulation of cell proliferation and migration (notably in cancer, e.g., breast cancer)
04

Disease associations

Cancer (notably breast cancer: overexpression promotes proliferation, EMT, metastasis)Autoimmune disease (negative regulator in experimental autoimmune encephalomyelitis, a model for multiple sclerosis)Inflammation (suppresses excessive immune response by myeloid cells)Suspected role in Diamond-Blackfan Anemia 4 and Hemochromatosis Type 2 (by association)
05

Safety considerations

No known drug safety challenges; theoretical concerns include risk of unwanted immune suppression or activation.

Beyond the preview

Go deeper on Probable G-protein coupled receptor 141 (GPR141).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable G-protein coupled receptor 141 (GPR141).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call